Bendamustine plus rituximab in MALT lymphoma

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{ca754924d631437fa3bf4b18166b8e14,

title = "Bendamustine plus rituximab in MALT lymphoma",

author = "Ferreri, {Andr{\'e}s J M}",

year = "2014",

doi = "10.1016/S2352-3026(14)00023-4",

language = "English",

volume = "1",

pages = "e88--e89",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Elsevier Ltd",

number = "3",

}

TY - JOUR

T1 - Bendamustine plus rituximab in MALT lymphoma

AU - Ferreri, Andrés J M

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84922009006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922009006&partnerID=8YFLogxK

U2 - 10.1016/S2352-3026(14)00023-4

DO - 10.1016/S2352-3026(14)00023-4

M3 - Article

AN - SCOPUS:84922009006

VL - 1

SP - e88-e89

JO - The Lancet Haematology

JF - The Lancet Haematology

SN - 2352-3026

IS - 3

ER -